Identification of Potential Drug Targets in <i>Helicobacter pylori</i> Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing

Identification of Potential Drug Targets in <i>Helicobacter pylori</i> Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing

The class 1 carcinogen, <i>Helicobacter pylori</i>, is one of the World Health Organization’s high priority pathogens for antimicrobial development. We used three subtractive proteomics approaches using protein pools retrieved from: chokepoint reactions in the BIOCYC database, the Kyoto...

Full description

Bibliographic Details
Main Authors: Kareem A. Ibrahim, Omneya M. Helmy, Mona T. Kashef, Tharwat R. Elkhamissy, Mohammed A. Ramadan
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pathogens
Subjects:
<i>Helicobacter pylori</i>
in silico
subtractive proteomics
drug targets
repurposing
chokepoint
Online Access:https://www.mdpi.com/2076-0817/9/9/747

Internet

https://www.mdpi.com/2076-0817/9/9/747

Similar Items